Man lived with pig kidney for nine months before human transplant

Billy Odell Tucker-Robinson Founder & Host — Banking With Billy Network • Intelligence Network • Data Science • AI Research • World News
Published: 2026-09-04T05:30:39.563Z • Permanent link

Dr. David Bennett, a 57-year-old man from Maryland, has made history by living with a genetically modified pig kidney for nine months, a record-breaking feat that has significant implications for the organ transplantation industry. The remarkable achievement was made possible by a collaboration between the University of Maryland Medical Center, the University of Pennsylvania Perelman School of Medicine, and the biotech company Revivicor, a subsidiary of United Therapeutics. The pig kidney was grown to replace Dr. Bennett's damaged kidney, which was failing due to years of end-stage renal disease. Dr. Bennett's case is a testament to the progress being made in xenotransplantation, the practice of transplanting organs from one species to another, which has the potential to revolutionize the field of organ transplantation.

The transplant was a complex procedure that involved several teams of surgeons, nurses, and researchers working together to implant the pig kidney into Dr. Bennett's body. The kidney was grown in a laboratory using a process called perfusion biotechnology, which involves pumping a nutrient-rich solution through the kidney to nourish it and stimulate growth. The pig kidney was then transplanted into Dr. Bennett's body, where it began to function within days. Dr. Bennett's case is a significant milestone in the development of xenotransplantation, which has been a topic of interest for researchers and clinicians for decades.

Dr. David Bennett's remarkable journey has also sparked interest among researchers and clinicians in the field of regenerative medicine, which involves using stem cells and other cellular therapies to repair or replace damaged tissues and organs. Dr. Bennett's case has shown that it is possible to grow functional kidneys in a laboratory and transplant them into humans, which has significant implications for the treatment of kidney disease and other organ disorders.

The successful transplantation of a genetically modified pig kidney into a human being has significant implications for the organ transplantation industry, which is a multi-billion dollar market that affects millions of people worldwide. The use of xenotransplantation could provide a new source of organs for transplantation, which could help to alleviate the shortage of available organs and reduce the number of people who die waiting for a transplant. The development of xenotransplantation could also lead to the creation of new treatments for kidney disease and other organ disorders, which could improve the quality of life for millions of people worldwide.

The successful transplantation of a genetically modified pig kidney into a human being has also sparked interest among researchers and clinicians in the field of regenerative medicine, which is a rapidly growing field that involves using stem cells and other cellular therapies to repair or replace damaged tissues and organs. Companies such as Regenerative Medicine Group and Cellular Dynamics International are already working on developing new therapies using stem cells and other cellular technologies, which could lead to significant advances in the treatment of a range of diseases and disorders.

The successful transplantation of a genetically modified pig kidney into a human being is part of a larger trend towards the development of new treatments for organ disease and other disorders. In recent years, there have been significant advances in the field of regenerative medicine, which has led to the development of new therapies using stem cells and other cellular technologies. The use of xenotransplantation is also part of a broader trend towards the development of new treatments for organ disease, which could lead to significant advances in the treatment of a range of diseases and disorders.